ELI LILLY & CO (LLY)
Clinical trial NCT07213804 updates: 1. primary completion date: 2028-04-01 → 2028-11-01 2. enrollment: 1080 → 1630 participants
Clinical trial NCT07213804 updates: 1. primary completion date: 2028-04-01 → 2028-11-01 2. enrollment: 1080 → 1630 participants
Clinical trial NCT06695169 updates: 1. completion date: 2026-11-01 → 2026-11-11 2. enrollment: 659 → 485 participants
Clinical trial NCT05696366: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT05629585 updates: 1. collaborators added: SWOG Clinical Trials Partnerships, LLC 2. collaborators removed: SWOG Clinical Trials Partnerships
Clinical trial NCT05090722 updates: 1. status: SUSPENDED → RECRUITING 2. primary completion date: 2026-10-01 → 2027-10-01
Clinical trial NCT05911295: primary completion date: 2026-06-30 → 2027-01-29.
Clinical trial NCT07254455 updates: 1. completion date: 2030-10-01 → 2031-10-01 2. primary completion date: 2028-06-01 → 2027-12-01
Clinical trial NCT07530289 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. primary completion date: 2026-06-03 → 2026-05-23 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07615179 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. primary completion date: 2026-05-30 → 2025-09-30 3. enrollment: 2214 → 4545 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07549490: start date: 2026-06-17 → 2026-06-18.